000 | 01648 a2200577 4500 | ||
---|---|---|---|
005 | 20250513031953.0 | ||
264 | 0 | _c19951106 | |
008 | 199511s 0 0 eng d | ||
022 | _a0890-9016 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPham, S M | |
245 | 0 | 0 |
_aCardiac transplantation at the University of Pittsburgh: 1994 update. _h[electronic resource] |
260 |
_bClinical transplants _c1994 |
||
300 |
_a121-5 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aActuarial Analysis |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aCause of Death |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDemography |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGraft Rejection |
650 | 0 | 4 |
_aHeart Transplantation _xmortality |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xadverse effects |
650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aKidney Diseases _xchemically induced |
650 | 0 | 4 |
_aLymphoproliferative Disorders _xetiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 |
_aPennsylvania _xepidemiology |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aSurvival Rate |
650 | 0 | 4 |
_aTacrolimus _xadverse effects |
700 | 1 | _aKormos, R L | |
700 | 1 | _aMurali, S | |
700 | 1 | _aKawai, A | |
700 | 1 | _aDemetris, A J | |
700 | 1 | _aHattler, B G | |
700 | 1 | _aWilliams, P A | |
700 | 1 | _aMcNamara, D | |
700 | 1 | _aRosenblum, W | |
700 | 1 | _aFricker, F J | |
773 | 0 |
_tClinical transplants _gp. 121-5 |
|
999 |
_c7546988 _d7546988 |